Matches in Wikidata for { <http://www.wikidata.org/entity/Q57098107> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q57098107 description "article scientifique publié en 2012" @default.
- Q57098107 description "artículu científicu espublizáu en febreru de 2012" @default.
- Q57098107 description "im Februar 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57098107 description "scientific article published on 09 February 2012" @default.
- Q57098107 description "wetenschappelijk artikel" @default.
- Q57098107 description "наукова стаття, опублікована в серпні 2012" @default.
- Q57098107 description "գիտական հոդված հրատարակված 2012 թվականի փետրվարի 9-ին" @default.
- Q57098107 name "The pulmonary pharmacology of [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide] (2NTX-99), an anti-atherotrombotic compound with therapeutic potential in pathological conditions that target lung vasculature" @default.
- Q57098107 name "The pulmonary pharmacology of [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide] (2NTX-99), an anti-atherotrombotic compound with therapeutic potential in pathological conditions that target lung vasculature" @default.
- Q57098107 type Item @default.
- Q57098107 label "The pulmonary pharmacology of [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide] (2NTX-99), an anti-atherotrombotic compound with therapeutic potential in pathological conditions that target lung vasculature" @default.
- Q57098107 label "The pulmonary pharmacology of [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide] (2NTX-99), an anti-atherotrombotic compound with therapeutic potential in pathological conditions that target lung vasculature" @default.
- Q57098107 prefLabel "The pulmonary pharmacology of [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide] (2NTX-99), an anti-atherotrombotic compound with therapeutic potential in pathological conditions that target lung vasculature" @default.
- Q57098107 prefLabel "The pulmonary pharmacology of [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide] (2NTX-99), an anti-atherotrombotic compound with therapeutic potential in pathological conditions that target lung vasculature" @default.
- Q57098107 P1433 Q57098107-48E49597-3E1D-472E-8E82-6BB1925E3AED @default.
- Q57098107 P1476 Q57098107-7445AF7A-B90E-4208-9A28-9F02009299AD @default.
- Q57098107 P2093 Q57098107-55F59018-A69B-41A0-A0ED-2436B878E8C5 @default.
- Q57098107 P2093 Q57098107-752DEDBB-062D-4C4B-8E1F-75315E24DBF0 @default.
- Q57098107 P2093 Q57098107-B379D6D1-7356-41ED-945C-62070AF369DF @default.
- Q57098107 P2093 Q57098107-BE689FC0-FE1F-460A-913F-26AD172395D2 @default.
- Q57098107 P2093 Q57098107-D2287962-434C-4135-B415-C8F2354A0C0F @default.
- Q57098107 P2093 Q57098107-D2CFE083-FBA9-4804-BDA6-EB39D9DE3ED1 @default.
- Q57098107 P304 Q57098107-09E236C8-0B93-4F42-ADB8-D425627DBF39 @default.
- Q57098107 P31 Q57098107-A31F52D9-41AB-421A-A5E4-48D041F3D35F @default.
- Q57098107 P356 Q57098107-2C34B4BA-6CDC-4906-91C2-F89289BB77E9 @default.
- Q57098107 P407 Q57098107-AE54768C-2FD8-4446-8481-2F5F824BE7F5 @default.
- Q57098107 P433 Q57098107-DFE2AA7A-DB3E-4B93-9801-E6D8D526F619 @default.
- Q57098107 P478 Q57098107-88AA8FAD-1038-4BFF-84E6-2CD8DDFAA65E @default.
- Q57098107 P50 Q57098107-61C6C96F-81E6-4C3E-B1B0-EA625334C87F @default.
- Q57098107 P577 Q57098107-FDB2E9A6-C4AB-49C7-B554-FFD04CEEF2BC @default.
- Q57098107 P698 Q57098107-0F194361-E07E-4CFD-A752-3595AB810AB9 @default.
- Q57098107 P921 Q57098107-A6045E18-4899-45C3-85D2-37EDCE885B12 @default.
- Q57098107 P356 J.PROSTAGLANDINS.2012.01.007 @default.
- Q57098107 P698 22342851 @default.
- Q57098107 P1433 Q15754476 @default.
- Q57098107 P1476 "The pulmonary pharmacology of [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide] (2NTX-99), an anti-atherotrombotic compound with therapeutic potential in pathological conditions that target lung vasculature" @default.
- Q57098107 P2093 "C Buccellati" @default.
- Q57098107 P2093 "C Casagrande" @default.
- Q57098107 P2093 "F Fumagalli" @default.
- Q57098107 P2093 "G C Folco" @default.
- Q57098107 P2093 "I Brivio" @default.
- Q57098107 P2093 "J Hodge" @default.
- Q57098107 P304 "116-121" @default.
- Q57098107 P31 Q13442814 @default.
- Q57098107 P356 "10.1016/J.PROSTAGLANDINS.2012.01.007" @default.
- Q57098107 P407 Q1860 @default.
- Q57098107 P433 "3-4" @default.
- Q57098107 P478 "98" @default.
- Q57098107 P50 Q41118865 @default.
- Q57098107 P577 "2012-02-09T00:00:00Z" @default.
- Q57098107 P698 "22342851" @default.
- Q57098107 P921 Q128406 @default.